Papillomavirus 

  • Author: John D Shanley, MD, MPH; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Dec 29, 2011
 

Background

Infections due to papillomaviruses are common and lead to a wide variety of clinical manifestations that involve the epidermal surfaces. Manifestations include common warts (verrucae vulgaris), palmo-plantar warts, flat warts (verrucae plana), oral warts, focal epithelia hyperplasia, epidermodysplasia verruciformis (EDV), genital warts (condyloma acuminata), Bowen papulosis, Bowen disease, papillomas of the mucosal surfaces, and intraepithelial neoplasias.

Strong evidence indicates that certain papillomaviruses are involved in cervical and genital cancers. Some have also been implicated in laryngeal/oral cancer and some lung cancers.

Genital human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States.

Plantar warts. Plantar warts. Flat wart. Flat wart.
Next

Pathophysiology

Papillomaviruses are small (55 nm) double-stranded DNA viruses. Papillomaviruses are widely disseminated in the animal kingdom, and more than 200 genotypes of HPV that infect the skin and mucosal surfaces have been characterized. These viruses are highly species-specific. Papillomaviruses have never been grown in vitro but have been characterized by molecular methods.

The genome of papillomaviruses is approximately 8000 base pairs divided into 3 major functional regions. The early (E) region codes for 6 nonstructural genes, several of which are associated with cellular transformation. The late (L) region codes for 2 structural proteins, L1 and L2, that form the capsid. The long control region is a noncoding region that regulates replication and gene function.

These viruses are classified by the molecular similarity of their genetic material and are assigned a genotype number.

The viruses infect the basal keratinocyte of the epidermis, presumably through disruptions of the skin or mucosal surface. At this location, the virus remains latent in the cell as a circular episome in low copy numbers. As the epidermal cells differentiate and migrate to the surface, the virus is triggered to undergo replication and maturation and, at the keratinic layer, the virus is present in high copy numbers and is shed in the exfoliation cells. The process of virus replication alters the character of the epidermis, resulting in cutaneous or mucosal excrescences known as warts. HPVs are broadly grouped into cutaneous and mucosal type, based on the clinical location of the lesion.

Although some overlap exists, most papillomaviruses have distinct anatomic predilections, infecting only certain epidermal sites, such as skin or genital mucosa. The virus has the potential to integrate into host DNA frequently with the loss of the early regulatory function. Numerous viral genotypes have the potential to transform cells and are associated with epidermal malignancies. This appears involve interactions of E6 and E7 proteins with host cell function. The mechanism for transformation is not known, but the viral DNA appears to integrate into the genome of the host cell.

Table 1. Association of HPV Types With Morphology and Site of Skin Lesions (Open Table in a new window)

LesionLocationHPV Genotype
Common wartMostly hands2, 4
Plantar wartBottom of feet1
Mosaic wartHands and feet2
Flat wartArms, face, knees3, 10, 28, 41
Butcher wartHand7
Extragenital Bowen diseaseUpper and lower extremities, head2, 3, 5, 16, 18, 20, 31, 33, 34, 54, 56, 58, 61, 62, 73
Macular plaques of epidermodysplasia verruciformisLight-exposed areas5, 8, 9, 12, 14, 15, 17, 19, 20, 21, 22, 23, 24, 25, 36, 47, 50

Table 2. HPV Types Associated With Anogenital Lesions (Open Table in a new window)

LesionsHPV Genotype
Genital warts6, 11
Flat condylomata6, 11, 16, 18, 31
Cervical intraepithelial neoplasia16, 18, 31, 33, 35, 39, 42, 43, 44, 45, 51, 52, 56
Bowen disease6, 11
Buschke-Löwenstein tumors6, 11
Vulvar intraepithelial neoplasia16 (occasionally 6, 11)
Cervical cancer16, 18 (strong association)
31, 33, 35, 45, 51, 52, 56 (moderate association)
6, 11, 42, 43, 44 (weak association)
Penile intraepithelial neoplasia16, 18
Anal intraepithelial neoplasia16 (rarely 6, 11, 18, 33)
Previous
Next

Epidemiology

Frequency

United States

The United States has no reporting system for HPV infections. Infections and the development of warts appear to be common throughout life. In general, in the past several decades, the prevalence of genital HPV infections is considered to have increased dramatically, and it is now one of the most common sexually transmitted diseases, with an estimated 6.2 million new infections per year. The frequency of genital infections is associated with the number of sexual partners and the age of sexual debut. In cervical neoplasias, the HPV genome can be detected in more than 95% of tumors.

Using data and self-collected cervicovaginal specimens from 4150 females, from consecutive National Health and Nutrition Examination Surveys (2003–2006), Hariri et al found HPV present in 42.5% of US females aged 14-59 years. The highest rate of infection is among young females aged 20-24 years.[1]

Mortality/Morbidity

Most common warts are of cosmetic concern and generally cause little problem unless their anatomic location induces mechanical problems. For example, plantar warts can disrupt ambulation because of their location. Laryngeal papillomas may disrupt breathing or speaking. Genital warts occasionally cause problems such as urethral obstruction. Condyloma acuminata can become extremely large, resulting in tissue breakdown or secondary infection. In the context of immune deficiency, such as HIV infection, the growth of warts due to HPV can be augmented, significantly enhancing the associated anatomical problems.

Verrucous warts in a patient with HIV infection. Verrucous warts in a patient with HIV infection.

The major morbidity and mortality related to HPV infections are due to the development of malignancies. While the vast majority of genital HPV infections resolve spontaneously, persistent infection can lead to neoplastic changes. Cervical cancer is the second most common cause of morbidity and death in women in the United States. Malignancies such as Bowen tumors may also lead to morbidity and death.

Race

HPV infections have no racial predilection.

Sex

HPV infections have no sexual predilection.

Age

People of any age may develop common warts. HPV infects more than 50% of sexually active adults. Genital infection generally occurs during the sexually active period in a person's life, and infections increase with the number of sexual partners.

Previous
 
 
Contributor Information and Disclosures
Author

John D Shanley, MD, MPH  Professor Emeritus, University of Connecticut; Professor of Preventive Medicine, Stony Brook Medical Center

John D Shanley, MD, MPH is a member of the following medical societies: American Association for the Advancement of Science, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Specialty Editor Board

Jeffrey D Band, MD  Professor of Medicine, Oakland University William Beaumont School of Medicine; Director, Division of Infectious Diseases and International Medicine, Corporate Epidemiologist, William Beaumont Hospital; Clinical Professor of Medicine, Wayne State University School of Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Charles V Sanders, MD  Edgar Hull Professor and Chairman, Department of Internal Medicine, Professor of Microbiology, Immunology and Parasitology, Louisiana State University School of Medicine at New Orleans; Medical Director, Medicine Hospital Center, Charity Hospital and Medical Center of Louisiana at New Orleans; Consulting Staff, Ochsner Medical Center

Charles V Sanders, MD is a member of the following medical societies: Alliance for the Prudent Use of Antibiotics, Alpha Omega Alpha, American Association for the Advancement of Science, American Association of University Professors, American Clinical and Climatological Association, American College of Physician Executives, American College of Physicians, American Federation for Medical Research, American Foundation for AIDS Research, American Geriatrics Society, American Lung Association, American Medical Association, American Society for Microbiology, American Thoracic Society, American Venereal Disease Association, Association for Professionals in Infection Control and Epidemiology, Association of American Medical Colleges, Association of American Physicians, Association of Professors of Medicine, Infectious Disease Society for Obstetrics and Gynecology, Infectious Diseases Society of America, Louisiana State Medical Society, Orleans Parish Medical Society, Royal Society of Medicine, Sigma Xi, Society of General Internal Medicine, Southeastern Clinical Club, Southern Medical Association, Southern Society for Clinical Investigation, and Southwestern Association of Clinical Microbiology

Disclosure: Nothing to disclose.

Eleftherios Mylonakis, MD  Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital

Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

References
  1. Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, et al. Prevalence of genital human papillomavirus among females in the United States, the national health and nutrition examination survey, 2003-2006. J Infect Dis. Aug 2011;204(4):566-73. [Medline].

  2. [Guideline] FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. May 28 2010;59(20):626-9. [Medline]. [Full Text].

  3. Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. Dec 23 2011;60:1705-8. [Medline].

  4. FDA. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. May 28 2010;59(20):626-9. [Medline].

  5. FDA. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. May 28 2010;59(20):630-2. [Medline].

  6. Ault KA. Human papillomavirus infections: diagnosis, treatment, and hope for a vaccine. Obstet Gynecol Clin North Am. Dec 2003;30(4):809-17. [Medline].

  7. Beutner KR, Ferenczy A. Therapeutic approaches to genital warts. Am J Med. May 5 1997;102(5A):28-37. [Medline].

  8. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. Jan 2003;16(1):1-17. [Medline].

  9. Carr J, Gyorfi T. Human papillomavirus. Epidemiology, transmission, and pathogenesis. Clin Lab Med. Jun 2000;20(2):235-55. [Medline].

  10. Cox JT. History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results. J Clin Virol. Jul 2009;45 Suppl 1:S3-S12. [Medline].

  11. Fazel N, Wilczynski S, Lowe L, Su LD. Clinical, histopathologic, and molecular aspects of cutaneous human papillomavirus infections. Dermatol Clin. Jul 1999;17(3):521-36, viii. [Medline].

  12. Huang CM. Human papillomavirus and vaccination. Mayo Clin Proc. Jun 2008;83(6):701-6; quiz 706-7. [Medline].

  13. Huh WK. Human papillomavirus infection: a concise review of natural history. Obstet Gynecol. Jul 2009;114(1):139-43. [Medline].

  14. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. May 5 1997;102(5A):3-8. [Medline].

  15. Sedlacek TV. Advances in the diagnosis and treatment of human papillomavirus infections. Clin Obstet Gynecol. Jun 1999;42(2):206-20. [Medline].

  16. Siddiqui MA, Perry CM. Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil). Drugs. 2006;66(9):1263-71; discussion 1272-3. [Medline].

  17. Tjalma WA, Arbyn M, Paavonen J, van Waes TR, Bogers JJ. Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer. Int J Gynecol Cancer. Sep-Oct 2004;14(5):751-61. [Medline].

  18. Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis. Oct 15 2002;35(Suppl 2):S210-24. [Medline].

Previous
Next
 
Verrucous warts in a patient with HIV infection.
Plantar warts.
Flat wart.
Table 1. Association of HPV Types With Morphology and Site of Skin Lesions
LesionLocationHPV Genotype
Common wartMostly hands2, 4
Plantar wartBottom of feet1
Mosaic wartHands and feet2
Flat wartArms, face, knees3, 10, 28, 41
Butcher wartHand7
Extragenital Bowen diseaseUpper and lower extremities, head2, 3, 5, 16, 18, 20, 31, 33, 34, 54, 56, 58, 61, 62, 73
Macular plaques of epidermodysplasia verruciformisLight-exposed areas5, 8, 9, 12, 14, 15, 17, 19, 20, 21, 22, 23, 24, 25, 36, 47, 50
Table 2. HPV Types Associated With Anogenital Lesions
LesionsHPV Genotype
Genital warts6, 11
Flat condylomata6, 11, 16, 18, 31
Cervical intraepithelial neoplasia16, 18, 31, 33, 35, 39, 42, 43, 44, 45, 51, 52, 56
Bowen disease6, 11
Buschke-Löwenstein tumors6, 11
Vulvar intraepithelial neoplasia16 (occasionally 6, 11)
Cervical cancer16, 18 (strong association)
31, 33, 35, 45, 51, 52, 56 (moderate association)
6, 11, 42, 43, 44 (weak association)
Penile intraepithelial neoplasia16, 18
Anal intraepithelial neoplasia16 (rarely 6, 11, 18, 33)
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.